Evotec SE logo

Evotec SE

FSX:EVT.DE

Overview | Financials
Company Name Evotec SE
Symbol EVT.DE
Currency EUR
Price 7.255
Market Cap 1,286,333,882
Dividend Yield 0%
52-week-range 5.06 - 21.69
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.
Website https://www.evotec.com

An error occurred while fetching data.

About Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.

Related Stocks

Fielmann Aktiengesellschaft logo

Fielmann Aktiengesellschaft

FIE.DE

47.4 EUR

SYNLAB AG logo

SYNLAB AG

SYAB.DE

11.06 EUR

Bumrungrad Hospital Public Company Limited logo

Bumrungrad Hospital Public Company Limited

BZ7A.F

6.7 EUR

Novavax, Inc. logo

Novavax, Inc.

NVV1.F

6 EUR

CureVac N.V. logo

CureVac N.V.

5CV.F

5.28 EUR

BB Biotech AG logo

BB Biotech AG

BBZA.DE

37.7 EUR

CompuGroup Medical SE & Co. KGaA logo

CompuGroup Medical SE & Co. KGaA

COP.DE

13.82 EUR

Dermapharm Holding SE logo

Dermapharm Holding SE

DMP.DE

30.15 EUR

Henry Schein Inc logo

Henry Schein Inc

HS2.DE

65.26 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD